Publications by authors named "Po-Shu Tu"

Article Synopsis
  • DNA methylation, specifically through the enzyme DNMT3A, is crucial for hematopoietic differentiation and is linked to blood cancers when mutated.
  • DNMT3A deficiency can increase the number of hematopoietic stem cells by restricting their differentiation, impacting blood cell formation.
  • Research shows that DNMT3A promotes erythrocytic differentiation in leukemia cell lines, and its nuclear translocation, influenced by ERK1/2 signaling, plays a significant role in this process.
View Article and Find Full Text PDF

Mutations in are prevalent in various myeloid and lymphoid malignancies. The most common R882 mutations inhibit methyltransferase activity of the remaining wild-type DNMT3A proteins at a heterozygous state due to their dominant-negative activity. Reports and COSMIC database analysis reveal significantly different frequencies of R882 mutations in myeloid versus T-cell malignancies, inspiring us to investigate whether downregulation of regulates malignancies of different lineages in a dose-dependent manner.

View Article and Find Full Text PDF

Camptothecin (CPT) has been used for colorectal cancer therapy. At low concentration of 10M, CPT modulates endothelial nitric oxide production following the phosphorylation of LKB1 Ser431, AMPK-α Thr172, eNOS Ser633 and Ser1177. Elevated nitric oxide (NO) was observed by FA-OMe fluorescent probe.

View Article and Find Full Text PDF